Your browser doesn't support javascript.
loading
Linear Accelerator-Based Radiosurgery of Grade I Intracranial Meningiomas.
Alatriste-Martínez, Sara; Moreno-Jiménez, Sergio; Gutiérrez-Aceves, Guillermo A; Suárez-Campos, José de Jesús; García-Garduño, Olivia Amanda; Rosas-Cabral, Alejandro; Celis-López, Miguel Ángel.
Afiliação
  • Alatriste-Martínez S; Radioneurosurgery Unit, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Mexico City, Mexico.
  • Moreno-Jiménez S; Radioneurosurgery Unit, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Mexico City, Mexico.
  • Gutiérrez-Aceves GA; Radioneurosurgery Unit, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Mexico City, Mexico.
  • Suárez-Campos JJ; Radioneurosurgery Unit, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Mexico City, Mexico.
  • García-Garduño OA; Radioneurosurgery Unit, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Mexico City, Mexico.
  • Rosas-Cabral A; Department of Medicine, Universidad Autónoma de Aguascalientes, Aguascalientes, Mexico.
  • Celis-López MÁ; Radioneurosurgery Unit, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Mexico City, Mexico.
World Neurosurg X ; 3: 100027, 2019 Jul.
Article em En | MEDLINE | ID: mdl-31225520
OBJECTIVE: To determine the local control rate and complication rate in the treatment of grade I intracranial meningiomas. METHODS: A retrospective study was performed of patients with grade I meningioma who received radiosurgery with a dedicated linear accelerator from January 2002 to August 2012 with a minimum follow-up of 2 years. We performed descriptive statistics, logistic regression, and progression-free survival analysis through a Kaplan-Meier curve. RESULTS: Seventy-five patients with 78 grade I meningiomas received radiosurgery, 39 underwent surgery plus adjuvant radiosurgery, and 36 only radiosurgery. The follow-up median time was 68 months (range, 35-120 months). The tumor control rate was 93%, the 5-year progression-free survival was 92% (95% confidence interval, 77%-98%). Acute toxicity was 2.6%, and grade 1-2 late toxicity was 26.6%. Postradiosurgery edema was the main late morbidity. Age >55 years was the only significant factor for attaining a response >75%. The background of surgery before radiosurgery was the only significant prognostic factor for showing edema (odds ratio 5.78 [95% confidence interval, 2.14-15.64]). CONCLUSIONS: The local control rate attained in our series is similar to that reported in other series worldwide; the acute toxicity rate was low and late toxicity was moderate.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies Idioma: En Revista: World Neurosurg X Ano de publicação: 2019 Tipo de documento: Article País de afiliação: México País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies Idioma: En Revista: World Neurosurg X Ano de publicação: 2019 Tipo de documento: Article País de afiliação: México País de publicação: Estados Unidos